Advertisement

Topics

Mylan agrees to pay $465M to settle EpiPen misclassification claims

06:21 EDT 18 Aug 2017 | SmartBrief

EpiPen maker Mylan agreed to pay $465 million as part of a final settlement deal with the Justice Department, resolving claim -More

Original Article: Mylan agrees to pay $465M to settle EpiPen misclassification claims

NEXT ARTICLE

More From BioPortfolio on "Mylan agrees to pay $465M to settle EpiPen misclassification claims"

Advertisement
Quick Search
Advertisement
Advertisement